Avantax Planning Partners, Inc. Axogen, Inc. Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $14,133 - $31,632	-827 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $28,159 - $46,229	827 New	827 $30,000
Q2 2018 Aug 13, 2018	SELL	$36.15 - $52.5 $28,920 - $42,000	-800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $19,520 - $32,200	800 New	800 $29,000

180

36.4M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.